• slidebg1
Investing in disruption, one company at a time

Irving Investors is a growth fund with a sector agnostic approach.
We employ a single name strategy to maximize alpha across the capital structure.

MANAGEMENT TEAM

Jeremy Abelson
JEREMY ABELSON
FOUNDER / PRINCIPAL
Jeremy founded Irving Investors in 2009 after two successful exits in the digital media space. He combines his experience as an entrepreneur with institutional investing to find long-term sustainable investments in the public and private markets. He has contributed as an expert on Fox Business News, CNN, CNBC, The NYTimes, The WSJ and more. He also speaks at NYU, Columbia Business School and the NY Media Summit. Jeremy is originally from San Mateo, CA and graduated from The University of Michigan.
CHRIS CHISM
Portfolio Manager / Head of Credit
Chris joined Irving Investors in July of 2014 and holds the title of Portfolio Manager and Head of Credit. Chris started his career managing Corporate Loan portfolios at Lehman Brothers and Morgan Stanley. Most recently, before joining Irving he managed a Credit focused Macro portfolio at Millennium Partners in New York. In addition to his focus on Credit, Chris is actively building Irving’s relationships and investments in the Private space. Chris is originally from Seattle, WA and graduated from Washington University in St. Louis with a BSBA in Finance, Accounting, and International Business, as well as a MSBA in Accounting.
MATHEW OOMMEN
Portfolio Manager - Equities
Mathew joined Irving Investors in 2013 and serves as a Portfolio Manager. Mathew started his career in Investment Banking at Thomas Weisel Partners. He then covered financial institutions as an Equity Research Associate at Collins Stewart and was on the Corporate Development team at MF Global. Most recently, before joining Irving, Mathew was at a middle market focused Private Equity firm. Mathew grew up in Dubai U.A.E. and graduated with a B.A. in Economics from Brown University.
Andrew Kalmar
Andrew Kalmar
Portfolio Manager - Life Sciences
Andrew joined Irving in 2019 as a Portfolio Manager with a dedicated Healthcare focus. Andrew runs a crossover strategy focusing on both public and private companies. Andrew began his career in 2002 working for the Lord Abbett Bond Debenture fund, which today remains one of the largest high-yield funds in existence. In 2004 he moved to Denver as a co-founder of Independence Capital Asset Partners, a growth focused hedge fund where he managed the healthcare portfolio. In 2015 he was a co-founder of Roubaix Capital which was a spin out of ICAP and he left in 2018. Andrew also actively consults with drug development companies as well as other investors.

THE IRVING STORY

Irving was founded in 2009 as a dedicated equity fund focused on disruptive technology and high growth opportunities, and has since expanded into Credit and Private investments.

The fund looks to form meaningful relationships with companies by offering its capital, expertise, and connections to promote growth and return on investment.

Irving has been involved in several successful private exits and is a trusted advisor and LP in Venture Capital funds.

The firm has offices in New York and Colorado.

OUR APPROACH

Our Approach

Locations

546 Fifth Avenue, 17th Floor
New York, NY
10036
205 Detroit St, Ste 400
Denver, CO
80206